IRIS Accounts Production v24.3.2.46 12170218 director 1.9.23 31.8.24 31.8.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh121702182023-08-31121702182024-08-31121702182023-09-012024-08-31121702182022-08-31121702182022-09-012023-08-31121702182023-08-3112170218ns15:EnglandWales2023-09-012024-08-3112170218ns14:PoundSterling2023-09-012024-08-3112170218ns10:Director12023-09-012024-08-3112170218ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3112170218ns10:SmallEntities2023-09-012024-08-3112170218ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3112170218ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3112170218ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3112170218ns10:AbridgedAccounts2023-09-012024-08-3112170218ns10:OrdinaryShareClass12023-09-012024-08-3112170218ns10:RegisteredOffice2023-09-012024-08-3112170218ns5:CurrentFinancialInstruments2024-08-3112170218ns5:CurrentFinancialInstruments2023-08-3112170218ns5:ShareCapital2024-08-3112170218ns5:ShareCapital2023-08-3112170218ns5:RetainedEarningsAccumulatedLosses2024-08-3112170218ns5:RetainedEarningsAccumulatedLosses2023-08-3112170218ns5:DeferredTaxation2023-08-3112170218ns5:DeferredTaxation2024-08-3112170218ns10:OrdinaryShareClass12024-08-31
REGISTERED NUMBER: 12170218 (England and Wales)










FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST AUGUST 2024

FOR

WU MEDICAL LIMITED

WU MEDICAL LIMITED (REGISTERED NUMBER: 12170218)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2024










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


WU MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST AUGUST 2024







DIRECTOR: Dr F Wu



REGISTERED OFFICE: c/o Michael Heaven & Associates Limited
47 Calthorpe Road
Edgbaston
BIRMINGHAM
West Midlands
B15 1TH



REGISTERED NUMBER: 12170218 (England and Wales)



ACCOUNTANTS: Michael Heaven & Associates Limited
Chartered Certified Accountants
47 Calthorpe Road
Edgbaston
BIRMINGHAM
B15 1TH



BANKERS: Santander UK PLC
Bridle Road
Bootle
Merseyside
L30 4GB



INCORPORATED: 22nd August 2019

WU MEDICAL LIMITED (REGISTERED NUMBER: 12170218)

ABRIDGED BALANCE SHEET
31ST AUGUST 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 29,910 39,953
Investments 5 100,000 -
129,910 39,953

CURRENT ASSETS
Debtors 11,849 8,414
Cash at bank 251,337 228,669
263,186 237,083
CREDITORS
Amounts falling due within one year 41,961 30,881
NET CURRENT ASSETS 221,225 206,202
TOTAL ASSETS LESS CURRENT
LIABILITIES

351,135

246,155

PROVISIONS FOR LIABILITIES 6 7,927 10,588
NET ASSETS 343,208 235,567

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 343,108 235,467
SHAREHOLDERS' FUNDS 343,208 235,567

WU MEDICAL LIMITED (REGISTERED NUMBER: 12170218)

ABRIDGED BALANCE SHEET - continued
31ST AUGUST 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st August 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31st August 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 5th November 2024 and were signed by:





Dr F Wu - Director


WU MEDICAL LIMITED (REGISTERED NUMBER: 12170218)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2024


1. STATUTORY INFORMATION

Wu Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the value of services provided to the extent that there is a right to consideration and is recorded at the value of the consideration due.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life:

Computer equipment - 25% straight line
Motor vehicles - 25% reducing balance

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable and loans from related parties.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


WU MEDICAL LIMITED (REGISTERED NUMBER: 12170218)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors
Short term debtors are measured at transaction price, less any impairment.

Creditors
Short term trade creditors are measured at the transaction price.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1st September 2023 58,377
Additions 1,201
At 31st August 2024 59,578
DEPRECIATION
At 1st September 2023 18,424
Charge for year 11,244
At 31st August 2024 29,668
NET BOOK VALUE
At 31st August 2024 29,910
At 31st August 2023 39,953

WU MEDICAL LIMITED (REGISTERED NUMBER: 12170218)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2024


5. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
Additions 100,000
At 31st August 2024 100,000
NET BOOK VALUE
At 31st August 2024 100,000

6. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 7,927 10,588

Deferred
tax
£   
Balance at 1st September 2023 10,588
Provided during the year (2,661 )
Balance at 31st August 2024 7,927

Provisions are recognised when the company has a legal or constructive obligation at the reporting date
as a result of a past event, it is probable that the company will be required to settle the obligation and the
amount of the obligation can be reliably estimated. Provisions are recognised at the best estimate of the
amount required to settle the obligation at the reporting date.

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

WU MEDICAL LIMITED (REGISTERED NUMBER: 12170218)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST AUGUST 2024


8. RELATED PARTY DISCLOSURES

At the year end the amount due to the director totalled £1,859. The loan is interest free and repayable on demand.